Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Oct 27, 2020 11:42am
77 Views
Post# 31788383

For those in the testing industry, business is pretty good

For those in the testing industry, business is pretty good

https://twitter.com/Sedancarandlimo/status/1320994721443897345

TL
 
@tlowdon
·
For those in the testing industry, business is pretty good right now. The US leads the world in SARS-CoV-2 testing per capita, averaging nearly 1.1M daily tests last week. At an average price per test of $140.59, expected annual spend at this rate would be $56 Billion.
 
 
Image
 
30
 
89
 
532
 
 
 
 
 
 
Testing for covid is a license to print money
 
 
374
 
835
 
3.9K

TL
 
@tlowdon
·
For those in the testing industry, business is pretty good right now. The US leads the world in SARS-CoV-2 testing per capita, averaging nearly 1.1M daily tests last week. At an average price per test of $140.59, expected annual spend at this rate would be $56 Billion.
 
 
Image
 
30
 
89
 
532
 
 
 
 
 
 
Testing for covid is a license to print money
 
 
374
 
835
 
3.9K

<< Previous
Bullboard Posts
Next >>